Dosing Adjustments for Ursodeoxycholic Acid in Renal Insufficiency

Metabolism and Excretion

The American Association for the Study of Liver Diseases recommends that ursodeoxycholic acid (UDCA) is a hydrophilic bile acid that is primarily metabolized in the liver and excreted through the bile, with its pharmacokinetics differing fundamentally from drugs like aminoglycosides that require strict adjustments based on renal function 1
The European Association for the Study of the Liver notes that UDCA does not depend on renal excretion for its elimination from the body, unlike many other medications 1
The American Thoracic Society guidelines indicate that aminoglycosides, such as streptomycin, amikacin, and capreomycin, require significant dose adjustments in renal insufficiency, with a recommended reduction in frequency to 2-3 times a week with doses of 12-15 mg/kg in patients with renal insufficiency 2

The American Association for the Study of Liver Diseases recommends a dose of 13-15 mg/kg/day as a single nightly dose for cholangiopathies, including primary sclerosing cholangitis and primary biliary cirrhosis, regardless of renal function 1
The European Association for the Study of the Liver suggests that this dosage remains constant even in patients with advanced chronic kidney disease 1

The American College of Chest Physicians guidelines state that anticoagulants require specific adjustments based on creatinine clearance 3

The American Association for the Study of Liver Diseases recommends that it is not necessary to calculate creatinine clearance to adjust the dose of UDCA 1
The European Association for the Study of the Liver notes that monitoring of serum drug levels is not required in patients with renal insufficiency 1

For primary biliary cholangitis, the American Association for the Study of Liver Diseases recommends 13-15 mg/kg/day of ursodeoxycholic acid as a single bedtime dose 4
For primary sclerosing cholangitis, doses of 13-15 mg/kg/day may improve liver biochemistry but not outcomes, according to the European Association for the Study of the Liver 5, 6
Higher doses of ursodeoxycholic acid (28-30 mg/kg/day) should be avoided as they may be harmful in late-stage liver disease, as recommended by the American College of Gastroenterology 4